The generic share of total prescriptions dispensed in the US increased from 14% when the Hatch-Waxman legislation was passed [1984] to 42% by 2000 and 92% today.
The generic share of total prescriptions dispensed in the US increased from 14% when the Hatch-Waxman legislation was passed [1984] to 42% by 2000 and 92% today.